se of eranda bhrusta haritaki in the management of painful menstruation (udavartani yonivayapada)
Phase 3
- Conditions
- Health Condition 1: N738- Other specified female pelvic inflammatory diseases
- Registration Number
- CTRI/2023/05/052281
- Lead Sponsor
- Dr Neha Yadav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 15 years to 45 years
Patient diagnosis with Udavartini Yonivayapada
Exclusion Criteria
Patient having Any Malignancy or Missed Period
Patient have diagnosed with HIV STD HCV
Patient having a pregnancy in midterm
Patient having any pelvic palpable pathology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in pain and discomfort in perimenstrual periodTimepoint: 12week <br/ ><br>The trial drug will be given for 3months with anupana and follow up after cessation of medicine
- Secondary Outcome Measures
Name Time Method State of constipation and also in apanavata gat vayadhiTimepoint: After analyzing all parameter the result will be assessed on the basis of symptomatic relief and improvement <br/ ><br> <br/ ><br>Partially improvement after 4 week-patient get 40 -60 percent relief sing and symptoms <br/ ><br> <br/ ><br>Improvement after 8 week -patient get 60-80 percent relief form sing and symptoms <br/ ><br> <br/ ><br>Cured after 12 week - patient get 80 -100 percent relief form sing and symptoms